Can we finally get ahead of drug shortages?

In this episode of Denatured, you’ll hear from Christina Smolke, co-founder & CEO at Antheia and Kyle Pudenz, senior vice president and head of data & AI product at Cencora. We explore why drug shortages are getting worse, and how combining predictive supply-chain analytics with agile, distributed manufacturing could finally make essential medicines more resilient and accessible.

> Listen on Spotify
> Listen on Apple Podcasts
> Listen on Amazon Music
> Listen on iheart
> Watch on YouTube

In this episode of Denatured, you’ll listen to Christina Smolke, co-founder & CEO at Antheia and Kyle Pudenz, senior vice president and head of data & AI product at Cencora. We examine the factors driving the growing threat of drug shortages and explore how predictive supply chain insights, paired with flexible distributed manufacturing, can help strengthen medicine availability and improve patient access.

Host

⁠Jennifer C. Smith-Parker, Director of Insights, BioSpace

Guests

Christina Smolke, Co-founder & CEO, Antheia

Kyle Pudenz, Senior Vice President, Head of Data & AI Product, Cencora

Disclaimer: The views expressed in this discussion by guests are their own and do not represent those of their organizations.

Jennifer C. Smith-Parker is Director of Insights at BioSpace. She has been been immersed for 20 years in healthcare, first as a journalist and editor before pivoting to corporate, brand, and product communications. A skilled storyteller, she is adept at creating diverse content across platforms and crafting narratives that drive engagement, strengthen reputation, and deliver measurable growth. You can reach her at Jennifer.Smith-Parker@BioSpace.com.
The BioSpace Insights teams performs research and analysis on industry trends for BioSpace and clients, producing industry reports, podcasts, events and articles.
MORE ON THIS TOPIC